Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...

Morgan Stanley lowered the firm’s price target on Johnson & Johnson to $163 from $175 and keeps an Equal Weight rating on the shares ...

From new leadership to product launches, here are five key updates from spine and orthopedic devicemakers since Jan. 15.

The company's multiple myeloma franchise, which includes Carvykti, stands to contribute significantly to its growth in 2025.

Prism Johnson Ltd. key Products/Revenue Segments include Cement, Sale of services, Other Operating Revenue and Scrap for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the company has ...

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

Solution Tree, a premier provider of K-12 professional development resources and services for educators, is pleased to announce the release of Culture Champions: Teachers Supporting a Healthy ...

Johnson & Johnson reported better-than-expected quarterly revenue and profit on higher sales of cancer drugs and some medical devices. But shares slipped 3.2% to $143.35 in Wednesday morning trading, ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...

Here are some of the most interesting products that Sears sold nearly 120 years ago. The wonderful world of copywriting before things like “laws” and “morals” is on full display in this 1902 catalog.

Nothing lasts forever. All good things come to an end. Yesterday is history. Unless you’re talking about one of your favorite discontinued products, in which case no words have the power to take their ...